Variant report
Variant | nsv511623 |
---|---|
Chromosome Location | chr19:51400775-51408842 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:165)
- CpG islands (count:61)
- Chromatin interactive region (count:8)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | ATF2 | chr19:51399719-51400959 | GM12878 | blood: | n/a | n/a |
2 | ATF2 | chr19:51399748-51400831 | GM12878 | blood: | n/a | n/a |
3 | BATF | chr19:51399841-51400784 | GM12878 | blood: | n/a | n/a |
4 | BCLAF1 | chr19:51399742-51400846 | GM12878 | blood: | n/a | n/a |
5 | BHLHE40 | chr19:51399738-51401225 | GM12878 | blood: | n/a | n/a |
6 | CBX3 | chr19:51402901-51403221 | K562 | blood: | n/a | n/a |
7 | CBX3 | chr19:51402777-51403266 | K562 | blood: | n/a | n/a |
8 | CEBPB | chr19:51399685-51400979 | GM12878 | blood: | n/a | n/a |
9 | CEBPB | chr19:51400913-51401149 | A549 | lung: | n/a | n/a |
10 | CHD1 | chr19:51399763-51401491 | GM12878 | blood: | n/a | n/a |
11 | CHD2 | chr19:51399758-51401200 | GM12878 | blood: | n/a | n/a |
12 | CTCF | chr19:51400920-51401070 | GM12870 | blood: | n/a | n/a |
13 | CTCF | chr19:51400974-51401073 | GM19240 | blood: | n/a | n/a |
14 | CTCF | chr19:51400988-51401080 | LNCaP | prostate: | n/a | n/a |
15 | CTCF | chr19:51400940-51401090 | HMEC | breast: | n/a | n/a |
16 | CTCF | chr19:51400920-51401070 | GM12864 | blood: | n/a | n/a |
17 | CTCF | chr19:51400960-51401110 | GM06990 | blood: | n/a | n/a |
18 | CTCF | chr19:51400920-51401070 | GM12869 | blood: | n/a | n/a |
19 | CTCF | chr19:51400940-51401090 | NHEK | skin: | n/a | n/a |
20 | CTCF | chr19:51400880-51401030 | HCT-116 | colon: | n/a | n/a |
21 | CTCF | chr19:51400936-51401108 | GM12891 | blood: | n/a | n/a |
22 | CTCF | chr19:51400940-51401090 | Hela-S3 | cervix: | n/a | n/a |
23 | CTCF | chr19:51400903-51401123 | GM19238 | blood: | n/a | n/a |
24 | CTCF | chr19:51400937-51401108 | NHEK | skin: | n/a | n/a |
25 | CTCF | chr19:51401000-51401150 | GM12873 | blood: | n/a | n/a |
26 | CTCF | chr19:51400900-51401050 | GM12874 | blood: | n/a | n/a |
27 | CTCF | chr19:51400965-51401036 | GM10248 | blood: | n/a | n/a |
28 | CTCF | chr19:51400860-51401130 | GM12869 | blood: | n/a | n/a |
29 | CTCF | chr19:51400920-51401116 | MCF-7 | breast: | n/a | n/a |
30 | CTCF | chr19:51400920-51401070 | HMEC | breast: | n/a | n/a |
31 | CTCF | chr19:51400980-51401130 | GM12865 | blood: | n/a | n/a |
32 | CTCF | chr19:51400915-51401118 | MCF-7 | breast: | n/a | n/a |
33 | CTCF | chr19:51400900-51401050 | GM12872 | blood: | n/a | n/a |
34 | CTCF | chr19:51400923-51401079 | GM19239 | blood: | n/a | n/a |
35 | CTCF | chr19:51400870-51401314 | HCT-116 | colon: | n/a | n/a |
36 | CTCF | chr19:51404137-51404143 | GM13976 | blood: | n/a | n/a |
37 | CTCF | chr19:51400940-51401090 | GM12875 | blood: | n/a | n/a |
38 | CTCF | chr19:51400926-51401271 | MCF-7 | breast: | n/a | n/a |
39 | CTCF | chr19:51400960-51401110 | A549 | lung: | n/a | n/a |
40 | CTCF | chr19:51404155-51404190 | GM13976 | blood: | n/a | n/a |
41 | CTCF | chr19:51400970-51401089 | Hela-S3 | cervix: | n/a | n/a |
42 | CTCF | chr19:51401020-51401170 | GM12865 | blood: | n/a | n/a |
43 | CTCF | chr19:51400880-51401030 | GM12871 | blood: | n/a | n/a |
44 | CTCF | chr19:51400911-51401120 | MCF-7 | breast: | n/a | n/a |
45 | CTCF | chr19:51400860-51401010 | HCT-116 | colon: | n/a | n/a |
46 | CTCF | chr19:51400960-51401110 | GM12878 | blood: | n/a | n/a |
47 | CTCF | chr19:51400940-51401090 | MCF-7 | breast: | n/a | n/a |
48 | CTCF | chr19:51400920-51401070 | GM06990 | blood: | n/a | n/a |
49 | CTCF | chr19:51400906-51401130 | MCF-7 | breast: | n/a | n/a |
50 | CTCF | chr19:51400960-51401067 | GM10266 | blood: | n/a | n/a |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr19:51400998-51401048 | H1-hESC | embryonic stem cell: | embryo |
2 | chr19:51400998-51401048 | ProgFib | skin: | n/a |
3 | chr19:51400998-51401048 | AG10803 | skin: | n/a |
4 | chr19:51400998-51401048 | SK-N-MC | brain: | n/a |
5 | chr19:51400998-51401048 | HCT-116 | colon: | n/a |
6 | chr19:51400998-51401048 | Hela-S3 | cervix: | n/a |
7 | chr19:51400998-51401048 | PANC-1 | pancreas: | n/a |
8 | chr19:51400998-51401048 | SK-N-SH_RA | brain: | n/a |
9 | chr19:51400998-51401048 | BJ | skin: | n/a |
10 | chr19:51400998-51401048 | PrEC | prostate: | n/a |
11 | chr19:51400998-51401048 | LNCaP | prostate: | n/a |
12 | chr19:51400998-51401048 | ovcar-3 | ovarian: | n/a |
13 | chr19:51400998-51401048 | AoSMC | blood vessel: | n/a |
14 | chr19:51400998-51401048 | NT2-D1 | testis: | n/a |
15 | chr19:51400998-51401048 | NB4 | blood: | n/a |
16 | chr19:51400998-51401048 | HRE | kidney: | n/a |
17 | chr19:51400998-51401048 | CMK | blood: | n/a |
18 | chr19:51400998-51401048 | K562 | blood: | n/a |
19 | chr19:51400998-51401048 | AG09309 | skin: | n/a |
20 | chr19:51400998-51401048 | HEEpiC | esophagus: | n/a |
21 | chr19:51400998-51401048 | IMR90 | lung: | fetal |
22 | chr19:51400998-51401048 | BE2_C | brain: | n/a |
23 | chr19:51400998-51401048 | HRPEpiC | eye: | n/a |
24 | chr19:51400998-51401048 | GM12891 | blood: | n/a |
25 | chr19:51400998-51401048 | Hepatocyte | liver: | n/a |
26 | chr19:51400998-51401048 | SAEC | small airway: | n/a |
27 | chr19:51400998-51401048 | HUVEC | blood vessel: | n/a |
28 | chr19:51400998-51401048 | HCM | heart: | n/a |
29 | chr19:51400998-51401048 | PFSK-1 | brain: | n/a |
30 | chr19:51400998-51401048 | U87 | brain: | n/a |
31 | chr19:51400998-51401048 | HepG2 | liver: | n/a |
32 | chr19:51400998-51401048 | HCPEpiC | choroid plexus: | n/a |
33 | chr19:51400998-51401048 | NHDF-neo | bronchial: | n/a |
34 | chr19:51400998-51401048 | GM06990 | blood: | n/a |
35 | chr19:51400998-51401048 | HL-60 | blood: | n/a |
36 | chr19:51400998-51401048 | A549 | lung: | n/a |
37 | chr19:51400998-51401048 | AG04450 | lung: | fetal |
38 | chr19:51400998-51401048 | HEK293 | kidney: | embryo |
39 | chr19:51400998-51401048 | GM12892 | blood: | n/a |
40 | chr19:51400998-51401048 | HPAEpiC | pulmonary alveolar: | n/a |
41 | chr19:51400998-51401048 | HMEC | breast: | n/a |
42 | chr19:51400998-51401048 | SKMC | muscle: | n/a |
43 | chr19:51400998-51401048 | GM12878 | blood: | n/a |
44 | chr19:51400998-51401048 | AG04449 | skin: | fetal |
45 | chr19:51400998-51401048 | HCF | heart: | n/a |
46 | chr19:51400998-51401048 | RPTEC | kidney: | n/a |
47 | chr19:51400998-51401048 | MCF10A-Er-Src | breast: | n/a |
48 | chr19:51400998-51401048 | MCF-7 | breast: | n/a |
49 | chr19:51400998-51401048 | AG09319 | gingival: | n/a |
50 | chr19:51400998-51401048 | Caco-2 | colon: | n/a |
(count:8 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr19:51391887..51394090-chr19:51400649..51402810,2 | MCF-7 | breast: | |
2 | chr19:51306246..51308382-chr19:51400037..51401731,2 | K562 | blood: | |
3 | chr19:51297092..51299196-chr19:51400128..51402648,2 | K562 | blood: | |
4 | chr19:51405117..51408111-chr19:51411398..51414932,3 | MCF-7 | breast: | |
5 | chr19:51402463..51404550-chr19:51522904..51525156,2 | MCF-7 | breast: | |
6 | chr19:51398615..51401717-chr19:51409067..51411982,3 | K562 | blood: | |
7 | chr19:51305899..51307746-chr19:51399929..51401731,2 | K562 | blood: | |
8 | chr19:51398902..51402347-chr19:51410482..51413710,3 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
KLKP1 | TF binding region |
KLKP1 | CpG island |
ENSG00000167747 | chromatin interactions |
ENSG00000197588 | chromatin interactions |
ENSG00000167749 | chromatin interactions |
ENSG00000129451 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs1610231 | chr19:51400775-51400776 | Enhancers Flanking Active TSS Weak transcription | TF binding regionChromatin interactive region | 4 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs2659107 | chr19:51400812-51400813 | Enhancers Flanking Active TSS Weak transcription | TF binding regionChromatin interactive region | 4 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs193014174 | chr19:51400813-51400814 | Enhancers Flanking Active TSS Weak transcription | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
4 | rs1560719 | chr19:51400836-51400837 | Enhancers Flanking Active TSS Weak transcription | TF binding regionChromatin interactive region | 4 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs115023171 | chr19:51400848-51400849 | Enhancers Flanking Active TSS Weak transcription | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
6 | rs577260527 | chr19:51400871-51400872 | Enhancers Flanking Active TSS Weak transcription | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
7 | rs143903993 | chr19:51400876-51400877 | Enhancers Flanking Active TSS Weak transcription | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
8 | rs369312426 | chr19:51400883-51400884 | Enhancers Flanking Active TSS Weak transcription | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
9 | rs144254238 | chr19:51400914-51400915 | Enhancers Flanking Active TSS Weak transcription | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
10 | rs531128829 | chr19:51400915-51400916 | Enhancers Flanking Active TSS Weak transcription | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
11 | rs541694088 | chr19:51400931-51400932 | Enhancers Flanking Active TSS Weak transcription | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
12 | rs561563719 | chr19:51400953-51400954 | Enhancers Flanking Active TSS Weak transcription | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
13 | rs528556350 | chr19:51400998-51400999 | Enhancers Flanking Active TSS Weak transcription | TF binding regionCpG islandChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
14 | rs114171752 | chr19:51400999-51401000 | Enhancers Flanking Active TSS Weak transcription | TF binding regionCpG islandChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
15 | rs561435746 | chr19:51401029-51401030 | Enhancers Weak transcription | TF binding regionCpG islandChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
16 | rs114724768 | chr19:51401079-51401080 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
17 | rs148705526 | chr19:51401085-51401086 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
18 | rs371150456 | chr19:51401087-51401088 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
19 | rs116686961 | chr19:51401093-51401094 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
20 | rs374488405 | chr19:51401202-51401203 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
21 | rs537386122 | chr19:51401204-51401205 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
22 | rs142463956 | chr19:51401290-51401291 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
23 | rs200932982 | chr19:51401301-51401302 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
24 | rs374047430 | chr19:51401383-51401384 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
25 | rs573829442 | chr19:51401392-51401393 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
26 | rs10409668 | chr19:51401401-51401402 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 4 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs552994055 | chr19:51401467-51401468 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
28 | rs577320004 | chr19:51401470-51401471 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
29 | rs567187912 | chr19:51401506-51401507 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
30 | rs183457454 | chr19:51401517-51401518 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
31 | rs150896065 | chr19:51401528-51401529 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
32 | rs574343756 | chr19:51401561-51401562 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
33 | rs575514576 | chr19:51401564-51401565 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
34 | rs543055689 | chr19:51401608-51401609 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
35 | rs188115696 | chr19:51401617-51401618 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
36 | rs372064161 | chr19:51401641-51401642 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
37 | rs7250437 | chr19:51401656-51401657 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
38 | rs139718345 | chr19:51401676-51401677 | Weak transcription Enhancers | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
39 | rs532670463 | chr19:51401692-51401693 | Weak transcription Enhancers | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
40 | rs375995287 | chr19:51401739-51401740 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
41 | rs115887456 | chr19:51401744-51401745 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
42 | rs569303003 | chr19:51401776-51401777 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
43 | rs8104538 | chr19:51401797-51401798 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
44 | rs3875143 | chr19:51401807-51401808 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
45 | rs567460263 | chr19:51401809-51401810 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
46 | rs534766123 | chr19:51401865-51401866 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
47 | rs76732076 | chr19:51401927-51401928 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
48 | rs529193085 | chr19:51401955-51401956 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
49 | rs116777269 | chr19:51401960-51401961 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
50 | rs547263579 | chr19:51401968-51401969 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Myelodysplastic syndrome | 17634407 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Cancer | 21637783 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Cancer | 20164919 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Prostate cancer | 18632612 | CNVD |
Ductal carcinoma | 22052326 | CNVD |
Congenital nephrotic syndrome | 18421352 | CNVD |
Astrocytoma | 17934521 | CNVD |
Leukemia | 17361228 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Breast cancer | 17603634 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
renal disease | 20603712 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Salivary gland adenoid cystic carcinoma | 17545515 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Chordoma | 18071362 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Bladder cancer | 21909424 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Wilms tumour | 21544195 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18852474 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Cervical cancer | 21062161 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Prostate cancer | 16573809 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Gastric adenocarcinoma | 19115996 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Adrenocortical carcinoma | 18281524 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Lung cancer | 18438408 | CNVD |
Basal cell lymphoma | 19029149 | CNVD |
Diffuse large b-cell lymphoma | 19029149 | CNVD |
Colorectal cancer | 16272173 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr19:51399400-51401400 | Enhancers | Primary B cells from peripheral blood | blood |
2 | chr19:51399800-51401000 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
3 | chr19:51399800-51401400 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
4 | chr19:51399800-51401600 | Enhancers | HMEC | breast |
5 | chr19:51399800-51403000 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
6 | chr19:51400000-51400800 | Enhancers | NHEK | skin |
7 | chr19:51400200-51401000 | Flanking Active TSS | GM12878-XiMat | blood |
8 | chr19:51400600-51402800 | Weak transcription | K562 | blood |
9 | chr19:51401000-51401600 | Enhancers | GM12878-XiMat | blood |
10 | chr19:51401400-51402600 | Weak transcription | Primary B cells from peripheral blood | blood |
11 | chr19:51401600-51402400 | Weak transcription | GM12878-XiMat | blood |
12 | chr19:51402400-51403200 | Enhancers | GM12878-XiMat | blood |
13 | chr19:51402600-51402800 | Enhancers | Primary B cells from peripheral blood | blood |
14 | chr19:51402800-51403200 | Enhancers | K562 | blood |
15 | chr19:51407200-51408000 | Bivalent/Poised TSS | ES-I3 Cell Line | embryonic stem cell |
16 | chr19:51407400-51407800 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
17 | chr19:51408600-51409400 | Weak transcription | GM12878-XiMat | blood |